Momentum Is Strong For Mirum Pharmaceuticals Inc (NASDAQ: MIRM)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Mirum Pharmaceuticals Inc is $2.64B. A total of 0.71 million shares were traded on the day, compared to an average of 419.55K shares.

In the most recent transaction, Howe Jolanda sold 564 shares of MIRM for 48.25 per share on Jul 02 ’25. After the transaction, the SVP, GLOBAL CONTROLLER now owns 2,903 company shares. In a previous transaction on Jul 03 ’25, Howe Jolanda sold 477 shares at 49.08 per share. MIRM shares that SVP, GLOBAL CONTROLLER owns now total 2,426.

Among the insiders who bought shares, JOLANDA MARIE HOWE acquired of 477 shares on Jul 03 ’25 at a per-share price of $49.08. In another insider transaction, Fairey William sold 3,203 shares at $48.42 per share on Jun 11 ’25. Company shares held by the Director now total 2,500.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, MIRM has a high of $54.23 and a low of $36.20.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. MIRM’s latest balance sheet shows that the firm has $156.54M in Cash & Short Term Investments as of fiscal 2021. There were $2.61M in debt and $42.60M in liabilities at the time. Its Book Value Per Share was $4.72, while its Total Shareholder’s Equity was $120.21M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MIRM is Buy with a score of 5.00.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.